Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Anonymous complaint alleged inappropriate entertainment/hospitality, biased sponsorship of delegates, and suspected off-label selling of Pergoveris at a fertility nurse meeting. PMCPA ruled…
Anonymous GP complained an osteoporosis audit pushed Adcal-D3. Panel found no inducement, but ruled 2 breaches of Clause 9.1 due to inconsistent/misleading…
Bayer Schering was found to have promoted Xarelto (rivaroxaban) before UK marketing authorisation via a UK exhibition stand and a journal insert,…
A nurse alleged she was suspended for refusing to share confidential unit/customer data from an infusion service facilitation programme. The Panel found…
A nurse challenged a Ferinject detail aid as inaccurate. The PMCPA found the CosmoFer administration chart and a “Single dose delivery” claim…
Anonymous complaint alleged inappropriate entertainment/hospitality, biased sponsorship of fertility nurses, and suspected off-label selling of Pergoveris. PMCPA ruled no breach of Clauses…
Anonymous GP alleged an osteoporosis audit pushed Adcal-D3. Panel found no inducement or product-link evidence, but ruled two breaches for poor standards:…
A nurse alleged she was suspended for refusing to share confidential unit/customer data from an infusion service facilitation programme. The Panel found…
Anonymous complaint questioned GSK’s POINTS COPD audit service as a potential rep monitoring/inducement tool. Panel found clear separation of promotional/non-promotional roles and…
A Lipitor mailer compared LDL-C lowering across statins but then presented a table implying only Lipitor/rosuvastatin/ezetimibe combos had outcomes trials. Panel ruled…
Complaint said Ezetrol ad implying “New NICE” guidance was misleading vs NICE lipid guideline. Panel found headline clearly referred to NICE TA132…
A Lipitor journal ad cited economic modelling that 37% vs 82% would hit cholesterol targets. PMCPA said the bold percentages read as…
A NeoClarityn journal ad implied clinically supported ‘anti-inflammatory’ action. PMCPA found it inconsistent with the SPC and misleading, breaching Clauses 3.2 and…
Anonymous complaint questioned GSK’s POINTS COPD audit service (consent complexity, data access, inducement). PMCPA found clear separation of promotional/non-promotional roles and no…
A Lipitor mailer compared LDL-C lowering across statins but then implied only Lipitor/rosuvastatin/ezetimibe combos had outcomes evidence. Panel found this misleading and…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
